Skip to content

Israeli Founders

biotech, healthtech

MSICS Pharma

Medical-grade psilocybin production and clinical trials for PTSD, depression, OCD

Total raised: $3.6M
Funding rounds: 1

MSICS Pharma is an Israeli biotech and healthtech company¹.

It has raised $3.6M across 1 funding round¹; the most recent was a round of $3.6M¹, announced May 3, 2026¹.

Founders: Roei Zerahia (CEO) and Omer Zerahia (CBO)¹.

Funding history

1 round

Funding rounds raised by MSICS Pharma, newest first
Round	Announced	Amount	Lead investors
Undisclosed stage	May 3, 2026	$3.6M

Founders

Roei ZerahiaCEO
Omer ZerahiaCBO

Investors

Which Israeli startups are similar to MSICS Pharma?

Undecimal Biobiotech
UltraSightmedtech
FIZE Medicalmedtech
Remepyhealthtech
QuantHealthhealthtech
Hemisphericai

Which startups share investors with MSICS Pharma?

Skapiondefense

Sources

1CTech, May 3, 2026. “Israeli startup bets on psychedelic mushrooms for mental health treatment | CTech”

How much funding has MSICS Pharma raised?

MSICS Pharma has raised $3.6M across 1 funding round.

What was MSICS Pharma’s latest funding round?

MSICS Pharma’s most recent round was a round of $3.6M, announced May 3, 2026.

Who founded MSICS Pharma?

MSICS Pharma was founded by Roei Zerahia and Omer Zerahia.

Who has invested in MSICS Pharma?

Investors in MSICS Pharma include Fusion VC, GlenRock and Gooday Investments.